CIK 0000105770 · Large accelerated filer
WEST PHARMACEUTICAL SERVICES INC
Sign in to watch- Ticker
- WST
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- PA
- Entity type
- operating
- EIN
- 231210010
- Phone
- 6105942900
- Business address
- 530 HERMAN O. WEST DRIVE, EXTON, PA, 19341
- Former names
- WEST CO INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,443,749
- in 2 filings, $2.7M under 10b5-1 plans
Net −$5,443,749. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-08 | Finch Norman D. Jr. SVP, GC & Corporate Secretary | Grant or award · Stock Option (Right to Buy) | +459 | $269.08 | $124K | 459 |
| 2025-09-30 | HAUGEN JANET BRUTSCHEA Director | Grant or award · Phantom Stock Unit | +48 | $262.33 | $13K | 162.16 |
| 2025-08-11 | McMahon Robert W. SVP & Chief Financial Officer | Grant or award · Rst. Stock Unit | +12,670 | 12,670 | ||
| 2025-08-11 | McMahon Robert W. SVP & Chief Financial Officer | Grant or award · Rst. Stock Unit | +3,168 | 3,168 | ||
| 2025-08-11 | McMahon Robert W. SVP & Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +7,647 | $240.33 | $1.8M | 7,647 |
| 2025-08-11 | McMahon Robert W. SVP & Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +7,137 | $240.33 | $1.7M | 7,137 |
| 2025-06-30 | HAUGEN JANET BRUTSCHEA Director | Grant or award · Phantom Stock Unit | +58 | $218.80 | $13K | 114.06 |
| 2025-05-12 | Campbell Shane Alden SVP, Proprietary Segment | Grant or award · Rst. Stock Unit | +1,891 | 1,891 | ||
| 2025-05-12 | Campbell Shane Alden SVP, Proprietary Segment | Grant or award · Rst. Stock Unit | +1,182 | 1,182 | ||
| 2025-05-12 | Campbell Shane Alden SVP, Proprietary Segment | Grant or award · Stock Options (Right to Buy) | +2,852 | $219.46 | $626K | 2,852 |
| 2025-05-06 | Michels Douglas A Director | Grant or award | +1,071 | 45,171.05 | ||
| 2025-05-06 | Pucci Paolo Director | Grant or award | +1,071 | 10,946.95 | ||
| 2025-05-06 | HAUGEN JANET BRUTSCHEA Director | Grant or award | +1,071 | 1,318.16 | ||
| 2025-05-06 | FRIEL ROBERT F Director | Grant or award | +1,071 | 4,681.98 | ||
| 2025-05-06 | LAI GOLDMAN MYLA Director | Grant or award | +1,071 | 19,423.93 | ||
| 2025-05-06 | Joseph Molly Director | Grant or award | +1,071 | 2,884.44 | ||
| 2025-05-06 | Hofmann Thomas W Director | Grant or award | +1,071 | 44,637.12 | ||
| 2025-05-06 | Keller Deborah L Director | Grant or award | +1,071 | 10,656.72 | ||
| 2025-05-06 | Feehery William F Director | Grant or award | +1,071 | 31,363.13 | ||
| 2025-05-06 | Lockhart Stephen H Director | Grant or award | +1,071 | 2,708.41 |
Page 6 of 13 · 257 trades